Zentraxa
Biotechnology, Test and Measurement
Founded in 1/1/17
Bristol, Bristol, City of, United Kingdom
For Profit
About Zentraxa
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
Company Metrics
- Employees: 1-10
- Monthly Visits: 6704
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 500000 GBP
- Last Funding: None (Series A)
- Funding Status: Early Stage Venture
Technology Stack
Zentraxa actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Test and Measurement
Headquarters: Bristol, Bristol, City of, United Kingdom